dc.contributor.author |
Ceban, Ilie |
|
dc.contributor.author |
Surev, Artiom |
|
dc.contributor.author |
Gheorghiu, Cristina |
|
dc.contributor.author |
Grib, Andrei |
|
dc.date.accessioned |
2020-07-03T13:40:18Z |
|
dc.date.available |
2020-07-03T13:40:18Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
CEBAN, Ilie, SUREV, Artiom, GHEORGHIU, Cristina, GRIB, Andrei. Risk prediction after primary percutaneous intervention in patients with non-ST-segment elevation myocardial infarction according to left ventricular ejection fraction. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 42. |
en_US |
dc.identifier.uri |
https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/10901 |
|
dc.description |
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova |
en_US |
dc.description.abstract |
Introduction. Primary percutaneous coronary intervention (pPCI) is the best-known therapy for
patients enduring non-ST-segment elevation myocardial infarction (NSTEMI). However, the risk
prediction in these patients remains problematic. Hence, reduced left ventricular ejection fraction
(LVEF) is the best available predictor of sudden cardiac death (SCD) in survivors of myocardial
infarction (MI). |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
MedEspera |
en_US |
dc.subject |
pPCI |
en_US |
dc.subject |
NSTEMI |
en_US |
dc.subject |
LVEF |
en_US |
dc.title |
Risk prediction after primary percutaneous intervention in patients with non-ST-segment elevation myocardial infarction according to left ventricular ejection fraction |
en_US |
dc.type |
Article |
en_US |